JPS62153224A - プラスミノゲン製剤 - Google Patents

プラスミノゲン製剤

Info

Publication number
JPS62153224A
JPS62153224A JP60293195A JP29319585A JPS62153224A JP S62153224 A JPS62153224 A JP S62153224A JP 60293195 A JP60293195 A JP 60293195A JP 29319585 A JP29319585 A JP 29319585A JP S62153224 A JPS62153224 A JP S62153224A
Authority
JP
Japan
Prior art keywords
plasminogen
preparation
solubilizer
sugar alcohol
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60293195A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0424331B2 (enrdf_load_html_response
Inventor
Kenji Tanaka
憲次 田中
Minoru Tsukada
稔 塚田
Yoshiro Iga
伊賀　善郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Priority to JP60293195A priority Critical patent/JPS62153224A/ja
Publication of JPS62153224A publication Critical patent/JPS62153224A/ja
Publication of JPH0424331B2 publication Critical patent/JPH0424331B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP60293195A 1985-12-27 1985-12-27 プラスミノゲン製剤 Granted JPS62153224A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60293195A JPS62153224A (ja) 1985-12-27 1985-12-27 プラスミノゲン製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60293195A JPS62153224A (ja) 1985-12-27 1985-12-27 プラスミノゲン製剤

Publications (2)

Publication Number Publication Date
JPS62153224A true JPS62153224A (ja) 1987-07-08
JPH0424331B2 JPH0424331B2 (enrdf_load_html_response) 1992-04-24

Family

ID=17791645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60293195A Granted JPS62153224A (ja) 1985-12-27 1985-12-27 プラスミノゲン製剤

Country Status (1)

Country Link
JP (1) JPS62153224A (enrdf_load_html_response)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015631A1 (fr) * 1993-01-11 1994-07-21 The Green Cross Corporation Preparation seche de plasminogene
CN107249622A (zh) * 2014-12-19 2017-10-13 普罗米蒂克生物治疗有限公司 包含纤溶酶原的药物组合物和其用途
TWI653982B (zh) 2015-12-18 2019-03-21 大陸商深圳瑞健生命科學研究院有限公司 Method for preventing or treating acute and chronic thrombosis
US11207387B2 (en) 2016-12-15 2021-12-28 Talengen International Limited Method and drug for preventing and treating obesity
US11389515B2 (en) 2016-12-15 2022-07-19 Talengen International Limited Method for mitigating heart disease
US11478535B2 (en) 2016-12-15 2022-10-25 Talengen International Limited Method for preventing and treating fatty liver

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57193418A (en) * 1981-05-14 1982-11-27 Behringwerke Ag Manufacture of plasminogen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57193418A (en) * 1981-05-14 1982-11-27 Behringwerke Ag Manufacture of plasminogen

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015631A1 (fr) * 1993-01-11 1994-07-21 The Green Cross Corporation Preparation seche de plasminogene
US10898553B2 (en) 2014-12-19 2021-01-26 Prometic Biotherapeutics, Inc. Pharmaceutical composition comprising plasminogen and uses thereof
US10441639B2 (en) 2014-12-19 2019-10-15 Prometic Biotherapeutics, Inc. Pharmaceutical composition comprising plasminogen and uses thereof
RU2711989C2 (ru) * 2014-12-19 2020-01-23 Прометик Байо Терапьютикс, Инк. Фармацевтическая композиция, содержащая плазминоген, и ее применение
CN107249622A (zh) * 2014-12-19 2017-10-13 普罗米蒂克生物治疗有限公司 包含纤溶酶原的药物组合物和其用途
CN107249622B (zh) * 2014-12-19 2021-08-03 普罗米蒂克生物治疗有限公司 包含纤溶酶原的药物组合物和其用途
US11633462B2 (en) 2014-12-19 2023-04-25 Prometic Biotherapeutics, Inc. Pharmaceutical composition comprising plasminogen and uses thereof
TWI653982B (zh) 2015-12-18 2019-03-21 大陸商深圳瑞健生命科學研究院有限公司 Method for preventing or treating acute and chronic thrombosis
US10864257B2 (en) 2015-12-18 2020-12-15 Talengen International Limited Method for prevention or treatment of acute and chronic thrombosis
US11207387B2 (en) 2016-12-15 2021-12-28 Talengen International Limited Method and drug for preventing and treating obesity
US11389515B2 (en) 2016-12-15 2022-07-19 Talengen International Limited Method for mitigating heart disease
US11478535B2 (en) 2016-12-15 2022-10-25 Talengen International Limited Method for preventing and treating fatty liver
US11547746B2 (en) 2016-12-15 2023-01-10 Talengen International Limited Method for treating coronary atherosclerosis and complications thereof

Also Published As

Publication number Publication date
JPH0424331B2 (enrdf_load_html_response) 1992-04-24

Similar Documents

Publication Publication Date Title
EP0444692B1 (en) Thrombin composition for oral administration
US5770700A (en) Liquid factor IX formulations
CA1329760C (en) Plasma and recombinant protein formulations in high ionic strength media
FI85335C (fi) Foerfarande foer framstaellning av lyofiliserad, farmaceutisk vaevnadsplasminogenaktivator(t-pa)-komposition.
FI85334C (fi) Foerfarande foer framstaellning av en vattenbaserad, vaevnadsplasminogenaktivator (t-pa) innehaollande, koncentrerad parenterad loesning.
JP3143470B2 (ja) ポリペプチド含有の皮下または筋肉内投与用医薬組成物
JPH0780782B2 (ja) 貯蔵安定で認容性のエリトロポエチン製剤及びその製法
JPH0672105B2 (ja) 血栓溶解剤及びその製法
JPH09512267A (ja) 因子ｉｘ用処方
JPH08245418A (ja) 安定なトランスグルタミナーゼ製剤およびそれらを製造する方法
JP2636499B2 (ja) プラスミノーゲン活性化因子蛋白の薬学的組成物
KR970005837B1 (ko) 조직 플라스미노겐 활성화제(t-PA) 활성을 갖는 고농도 단백질 용액의 제조방법, t-PA 활성을 갖는 단백질 용액, 및 이러한 용액을 포함하는 섬유소 용해성 조성물
US20030170207A1 (en) Stable aqua formulation of interferon, the preparation method and the uses thereof
JP2001500876A (ja) 液体形態の改良された安定性を有するコルチコトロピン放出因子の医薬製剤
JP4129994B2 (ja) 組織因子凝固系インヒビター含有血管新生阻害剤
EP0124018B1 (en) Pharmaceutical preparation containing purified fibronectin
JPS62153224A (ja) プラスミノゲン製剤
EP0612530A2 (en) Pharmaceutical preparations containing tumor cytotoxic factor
AU636653B2 (en) Stabilized leukocyte-interferons
CA1198672A (en) Fibrinolytically active agent and a method for the preparation thereof
JPH0684965B2 (ja) 血液製剤中の不適合反応原因物質の試験法
WO1980001039A1 (en) Fibrinolytic material and process for producing same
JPH05345728A (ja) 非グリコシル化還元型組換えヒトｉｌ２の安定化医薬組成物及びその製造方法
JPH0296536A (ja) プラスミノゲン乾燥製剤
CA2046598C (en) T-pa solubilisation